Be Clinical raises ₹21 Cr for clinical skincare expansion
What's the deal? D2C skincare startup Be ClinicalDealroom has a profile for this one. Try Dealroom → has raised ₹21 Cr (about $2.2 million) in a seed extension round led by Sauce, with participation from existing investor V3 VenturesDealroom has a profile for this one. Try Dealroom →. Angel backers included Sangeet AgrawalDealroom has a profile for this one. Try Dealroom →, Navin ParwalDealroom has a profile for this one. Try Dealroom → and Arjun PurkayasthaDealroom has a profile for this one. Try Dealroom →.
Where does the money go? Founded by Hemangi DhirDealroom has a profile for this one. Try Dealroom → and launched in 2025 after two years of R&D, Be Clinical develops clinically tested products with dermatologically active ingredients. It plans to use the capital to strengthen R&D, expand its skin, body and haircare portfolio, scale manufacturing, enter new markets, grow its team and deepen clinical testing.
What it means. Be Clinical says it has delivered 1.2 lakh orders since launch, with its website as the primary sales channel and additional availability on Amazon and Flipkart. The company previously raised ₹6 Cr in a seed round led by V3 Ventures, following an earlier ₹2 Cr round from Titan CapitalDealroom has a profile for this one. Try Dealroom → and P-TALDealroom has a profile for this one. Try Dealroom →.
Read more: Inc42
Image credit: Be Clinical
